• Bradykinin: Mechanistic Leverage for Translational Vascular

  2026-06-08

  This thought-leadership article explores the mechanistic power of Bradykinin as an endothelium-dependent vasodilator, providing translational researchers with actionable guidance for cardiovascular, inflammation, and pain pathway models. By integrating foundational biology, experimental best practices, and insights from contemporary literature, we chart a strategic path for leveraging APExBIO’s Bradykinin (BA5201) in advanced research—escalating the discussion beyond conventional product pages and addressing the future of vascular permeability modulation and smooth muscle contraction studies.

• Chrysin Potentiates Sunitinib Sensitivity in RCC via Ferropt

  2026-06-07

  A recent study reveals that chrysin, a natural flavonoid, enhances sensitivity of renal cell carcinoma (RCC) cells to sunitinib by inducing ferroptosis through the PI3K/Akt/GPX4 signaling axis. These findings highlight a promising strategy to overcome drug resistance in RCC using combination therapies targeting ferroptosis.

• URB597: Precision FAAH Inhibition for Neuroinflammation and

  2026-06-06

  Explore the unique role of URB597 as a highly selective FAAH inhibitor for advanced endocannabinoid research. This article provides a distinct, in-depth analysis of its applications in neuroinflammation, pain models, and assay optimization—contrasting prior content with practical insights.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-06-05

  The reference study demonstrates that phenothiazines, including perphenazine, enhance macrophage antibacterial capacity by inducing reactive oxygen species (ROS) production and autophagy, offering a host-directed strategy against intracellular pathogens. This mechanistic insight may inform future approaches to overcoming antibiotic resistance and optimizing host-pathogen research workflows.

• Annexin V-FITC/PI Apoptosis Assay Kit: Practical Protocol Gu

  2026-06-05

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, fluorescence-based identification and quantification of early and late apoptotic cells, as well as distinguishing necrotic events. It is well-suited for flow cytometry and fluorescence microscopy, but should not be used for diagnostic or clinical decision-making due to its research-only designation.

• Bile Acid Metabolism Subtypes Reveal Immune Markers in CRC P

  2026-06-04

  Feng et al. introduce a bile acid metabolism-based molecular subtyping approach to colorectal cancer (CRC), identifying CLCA1, UGT2A3, and ZG16 as immune dysfunction markers associated with poor prognosis. Their integrative analysis links bile acid metabolic states to tumor immune microenvironment composition and clinical outcomes, offering new biomarker and therapeutic avenues.

• Triacetin (Glyceryl Triacetate): Applied Protocols and Workf

  2026-06-04

  Triacetin (glyceryl triacetate) is redefining experimental design in oncology, metabolic, and ocular research. This guide unpacks best practices, troubleshooting tips, and protocol enhancements for researchers leveraging APExBIO’s Triacetin in advanced life science assays.

• Eicosapentaenoic Acid (EPA): Mechanisms and Research Utility

  2026-06-03

  Eicosapentaenoic Acid (EPA) is a rigorously characterized EPA omega-3 fatty acid with established lipid-lowering and anti-inflammatory properties. Its cellular actions include membrane incorporation and inhibition of key pathological processes relevant to cardiovascular disease research. EPA’s mechanistic clarity and QC profile make it a reference compound for experimental workflows.

• EPZ5676: DOT1L Inhibitor Advancing MLL Leukemia Research

  2026-06-03

  EPZ5676 stands out as a potent and selective DOT1L inhibitor, enabling precise interrogation of H3K79 methylation and MLL-rearranged leukemia pathways. This article unpacks experimental workflows, advanced applications, and troubleshooting strategies to maximize assay reliability with EPZ5676 in epigenetic and leukemia research.

• CPI-613 in Tumor Cell Metabolism Studies: Applied Workflows

  2026-06-02

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) enables researchers to dissect mitochondrial vulnerabilities in tumor cells with precision, targeting PDH and KGDH for robust apoptosis and metabolism assays. This guide details optimized protocols, advanced applications in acute myeloid leukemia and NSCLC studies, and troubleshooting strategies to maximize reproducibility with APExBIO’s trusted reagent.

• GLT-1 Upregulation Attenuates TBI via CB1-CREB Pathway Inhib

  2026-06-02

  This study demonstrates that enhancing GLT-1 expression in a mouse model of traumatic brain injury (TBI) reduces neuronal apoptosis and cognitive dysfunction by suppressing the CB1-CREB signaling pathway. The findings provide mechanistic insight into the regulation of glutamate homeostasis and highlight the utility of CB1 receptor antagonists in neuroprotection research.

• FH1 Small Molecule: Redefining iPS-Derived Hepatocyte Matura

  2026-06-01

  Discover how FH1, a small molecule from APExBIO, uniquely advances cultured hepatocyte function and iPS cell differentiation. This in-depth article explores the scientific mechanisms and practical assay implications that set FH1 apart in liver cell research.

• DMH1 ALK2 Inhibitor: Applied Workflows for Organoid & NSCLC

  2026-06-01

  Unlock precise BMP pathway control in organoid engineering and non-small cell lung cancer research with DMH-1, a highly selective ALK2 inhibitor. This guide delivers stepwise protocols, troubleshooting insights, and advanced use-cases for maximizing experimental success.

• Biochemical Features of GOB-38 β-Lactamase in E. anophelis

  2026-05-31

  This study characterizes the novel GOB-38 metallo-β-lactamase in Elizabethkingia anophelis, revealing its broad substrate specificity and unique active site composition. The findings provide key insights into mechanisms of multidrug resistance and potential horizontal gene transfer between clinically relevant pathogens.

• DOTAP: Mechanistic Leverage and Strategy for Translational G

  2026-05-30

  Explore how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) empowers translational researchers to optimize gene delivery, bridge immunometabolic insights, and drive innovation in functional genomics and next-generation therapeutics. This article offers mechanistic depth, protocol guidance, and strategic perspective, while contextualizing DOTAP’s role amid the evolving landscape of nano-enabled nucleic acid delivery.

444 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page